1

Pyxis Oncology

Oncology

www.pyxisoncology.com

HBM contact: Dr Emil Bujak

Company status: private

Pyxis is developing a differentiated portfolio of biologics, including antibody-drug conjugates (ADCs) and immunotherapies, to improve the lives of patients with difficult-to-treat cancers.

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171